Treatment of pain attributed to plantar fasciitis with botulinum toxin A: A short-term, randomized, placebo-controlled, double-blind study

American Journal of Physical Medicine and Rehabilitation

Volumn 84, Issue 9, 2005, Pages 649-654

  Babcock, Mary S ^a,b   Foster, Leslie ^a,b   Pasquina, Paul ^a,b   Jabbari, Bahman ^a,b,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Botox; Botulinum Toxin A; Foot; Pain; Plantar Fasciitis; Sports Injuries

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CALCANEUS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; PAIN; PLANTAR FASCIITIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

ADULT; AGED; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FASCIITIS, PLANTAR; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES;

EID: 24344499551     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.phm.0000176339.73591.d7     Document Type: Article

References (33)

1. De Maio M, Paine R, Maaangine RF, et al: Plantar fasciitis. Orthopedics 1993;16:1153-63
2. Young CC, Rutherford DS, Niedfeldt MW: Treatment of plantar fasciitis. Am Fam Physician 2001;64:570
3. Ryan J: Use of posterior night splints in the treatment of plantar fasciitis. Am Fam Physician 1995 52:891-8
4. Davis PF, Severud E, Baxter DE: Painful heel syndrome: Results of nonoperative treatment. Foot Ankle Int 1994;15:531-5
5. Childers MK: Use of Botulinum Toxin A in Pain Management. Columbia, MO, Academic Information Systems, 1999
6. Foster L, Clapp L, Erickson M, et al: Botulinum toxin A and chronic low back pain. Neurology 2001;56:1290-3
7. Barrett SL, O'Mally R: Plantar fasciitis and other causes of heel pain. Am Fam Physician 1999;59:2200-6
8. Childers MK, Wilson DJ, Galate JF, et al: Treatment of painful muscle syndromes with botulinum toxin: A review. J Back Musculoskeletal Rehabil 1998;10:89-96
9. Lang AM: A pilot study of botulinum toxin type A (Botox), administered using a novel injection technique, for the treatment of myofascial pain. Am J Pain Manage 2000;10:105-9
10. Wheeler AH, Goolkasian P, Gretz SS: A randomized, double blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine 1998;23:1662-6
11. Silberstein S, Mathew N, Saper J, et al: Botulinum toxin type A as a migraine preventive treatment: For the BOTOX Migraine Clinical Research Group. Headache 2000;40:445-50
12. Ondo W, Vuong K, Derman H: Botulinum toxin A for chronic daily headache: A randomized, placebo-controlled, parallel design study. Cephalalgia 2004;24:60-5
13. Cheshire WP, Abashian SW, Mann JD: Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994;59:65-9
14. Welch MJ, Purkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000;38:245-58
15. Sanchez-Prieto J, Sihra TS, Evans D, et al: Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes. Eur J Biochem 1987;165:675-81
16. Cui ML, Khanijou S, Rubino J, et al: Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 2004;107:125-33
17. Filippi GM, Errico P, Santarelli R, et al: Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol 1993;113:400-4
18. Rand MJ, Whaler RC: Impairment of sympathetic transmission by botulinum toxin. Nature 1965;206:588-91
19. Schepsis AA, Leach RE, Gorzyca J: Plantar fasciitis: Etiology, treatment, surgical results, and review of the literature. Clin Orthop 1991;266:185-96
20. Kane D, Greaney T, Bresnihan B, et al: Ultrasound guided injection of recalcitrant plantar fasciitis. Ann Rheum Dis 1998;57:383-4
21. Downie WW, Leatham PA, Rhind VM, et al: Studies with pain rating scales. Ann Rheum Dis 1978;37:378-81
22. Ferraz MB, Quaresma MR, Aquino LRL, et al: Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 1990;17:1022-4
23. Reeves JL, Jauger B, Graff-Radford SB: Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity. Pain 1986;24:313-21
24. Buchbinder R, Ptasznik R, Gordon J, et al: Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis: A randomized controlled trial. JAMA 2002;288:1364-72
25. Hefferman G, Khan F, Awan N, et al: A comparison of outcome score in os calcis fractures. Irish J Med Sci 2000;169:127-8
26. Myerson MS, Fisher RT, Burgess AR, et al: Fracture dislocations of the tarsometarsal joints: End results correlated with pathology and treatment. Foot Ankle 1986;6:225-42
27. Sriwantankul K, Kelvie W, Lasagna L, et al: Studies with different types of visual analogue scales for measurement of pain. Clin Pharmacol Ther 1983;34:234-9
28. Huskisson EC: Measurement of pain. Lancet 1974;2:1127-31
29. Plantar fascia and plantar muscles of the foot, in Williams PL, Banister LH, Berry MM, et al (eds): Gray's Anatomy, ed 38. Edinburgh, Churchill Livingston, 1995, pp 891-7
30. Akfirat M, Sen C, Gunes T: Ultrasonographic appearance of the plantar fasciitis. Clin Imaging 2003;27:353-7
31. Alfredson H, Lorentzon R: Chronic tendon pain: No sign of inflammation but high concentration of glutamate. Implications for treatment? Curr Drug Targets 2002;3:43-54
32. Roberts WJ: A hypothesis on the physiological basis of causalgia and related pains. Pain 1986;24:297-311
33. Lee HJ, Lee DW, Park YH, et al: Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol Surg 2004;30:867-71